Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Drug Shortages: FDA Says Market Must Reward Production Quality

Executive Summary

FDA officials state in journal article that manufacturers are not incentivized to ensure quality and base competition entirely on price.


Related Content

Pharmaceutical Quality And Generic Drugs: Janet Woodcock Explains Her Vision
ANDA Backlog Withdrawals May Stimulate Secondary Market By Foreign Firms
Drug Shortages: FDA Wants Ideas To Boost Manufacturing Quality For Strategic Plan
FDA Shortage Notification Mandate May Not Extend To Biologics
FDA And Generic Drug Quality: Turning Point, Or Precipice?
FDASIA Is Signed, Not That White House Wanted Anyone To Notice
Did PDUFA V Pass Too Quickly?
Drug Shortages Mostly FDA’s Fault, House Oversight Committee Concludes
Medicare Reimbursement Rate Targeted As Culprit For Drug Shortages
To Prevent Drug Shortages, Don't Look To Inspections, FDA Says


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts